Joël Cogneau

746 total citations
16 papers, 301 citations indexed

About

Joël Cogneau is a scholar working on General Health Professions, Public Health, Environmental and Occupational Health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Joël Cogneau has authored 16 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in General Health Professions, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Joël Cogneau's work include Health, Medicine and Society (6 papers), Healthcare Systems and Practices (5 papers) and Clinical practice guidelines implementation (4 papers). Joël Cogneau is often cited by papers focused on Health, Medicine and Society (6 papers), Healthcare Systems and Practices (5 papers) and Clinical practice guidelines implementation (4 papers). Joël Cogneau collaborates with scholars based in France, Niger and United Kingdom. Joël Cogneau's co-authors include Étienne Mullet, François Liard, Gérard Chasseigne, Paul Clay Sorum, F Fagnani, André Grimaldi, B. Detournay, B Charbonnel, Beverley Balkau and Jean Tichet and has published in prestigious journals such as PLoS ONE, Obesity and BMJ Open.

In The Last Decade

Joël Cogneau

15 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joël Cogneau France	10	90	85	69	39	38	16	301
Pieralessandro Lasalvia Colombia	10	34 0.4×	54 0.6×	39 0.6×	37 0.9×	20 0.5×	52	336
Janine Alessi Brazil	8	57 0.6×	95 1.1×	26 0.4×	38 1.0×	35 0.9×	24	334
David E. Kloecker United Kingdom	10	30 0.3×	87 1.0×	29 0.4×	17 0.4×	33 0.9×	15	308
Leonardo Maurício Diniz Brazil	9	197 2.2×	220 2.6×	28 0.4×	50 1.3×	11 0.3×	15	446
Mary Burden United Kingdom	10	40 0.4×	172 2.0×	70 1.0×	20 0.5×	7 0.2×	36	316
John Connolly United States	9	76 0.8×	32 0.4×	30 0.4×	28 0.7×	59 1.6×	24	343
Virginia Signal New Zealand	11	80 0.9×	37 0.4×	117 1.7×	63 1.6×	56 1.5×	23	369
Nathalie Saad Canada	9	49 0.5×	59 0.7×	18 0.3×	80 2.1×	19 0.5×	23	254
Katarzyna Kissimova‐Skarbek Poland	12	55 0.6×	168 2.0×	39 0.6×	35 0.9×	6 0.2×	19	318
Christie Schumacher United States	7	25 0.3×	175 2.1×	75 1.1×	25 0.6×	7 0.2×	32	315

Countries citing papers authored by Joël Cogneau

Since Specialization

Citations

This map shows the geographic impact of Joël Cogneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joël Cogneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joël Cogneau more than expected).

Fields of papers citing papers by Joël Cogneau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joël Cogneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joël Cogneau. The network helps show where Joël Cogneau may publish in the future.

Co-authorship network of co-authors of Joël Cogneau

This figure shows the co-authorship network connecting the top 25 collaborators of Joël Cogneau. A scholar is included among the top collaborators of Joël Cogneau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joël Cogneau. Joël Cogneau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

1.

Guellich, Aziz, Nadia Oubaya, Joël Cogneau, et al.. (2025). Identifying patterns of multimorbidity, polypharmacy and frailty in the elderly: a clustering analysis of baseline data from a French, randomised, controlled trial in primary care. BMJ Open. 15(6). e083584–e083584. 1 indexed citations

2.

Frappé, Paul, et al.. (2020). Anticoagulants’ Safety and Effectiveness in General Practice: A Nationwide Prospective Cohort Study. The Annals of Family Medicine. 18(2). 131–138. 6 indexed citations

3.

Frappé, Paul, et al.. (2017). Areas of improvement in anticoagulant safety. Data from the CACAO study, a cohort in general practice. PLoS ONE. 12(4). e0175167–e0175167. 5 indexed citations

4.

Norton, Joanna, C. Pommié, Joël Cogneau, et al.. (2011). Beliefs and Attitudes of French Family Practitioners toward Depression: The Impact of Training in Mental Health. The International Journal of Psychiatry in Medicine. 41(2). 107–122. 15 indexed citations

5.

Vierron, Emilie, Jean‐Michel Halimi, Jean Tichet, et al.. (2009). Center Effect on Ankle–Brachial Index Measurement When Using the Reference Method (Doppler and Manometer): Results From a Large Cohort Study. American Journal of Hypertension. 22(7). 718–722. 8 indexed citations

6.

Vol, Sylviane, Beverley Balkau, Céline Lange, et al.. (2009). Chez qui dépister le diabète de type 2 en France ? Un score prédictif issu de l’étude prospective D.E.S.I.R.. Médecine des Maladies Métaboliques. 3(2). 198–202.

7.

Cogneau, Joël, et al.. (2007). Écarts entre le référentiel et la pratique dans le diabète de type 2. La Presse Médicale. 36(5). 764–770. 12 indexed citations

8.

Péan, Franck, N. Bellili, Bernard Royer, et al.. (2006). ABCA1 Single Nucleotide Polymorphisms on High‐Density Lipoprotein‐Cholesterol and Overweight: the D.E.S.I.R. Study. Obesity. 14(11). 1874–1879. 44 indexed citations

9.

Cogneau, Joël, et al.. (2006). Pourquoi les médecins généralistes n'observent-ils pas les recommandations de bonnes pratiques cliniques ? L'exemple du diabète de type 2. Sciences sociales et santé. 24(2). 75–75. 22 indexed citations

10.

Cogneau, Joël, et al.. (2006). Pourquoi les médecins généralistes n'observent-ils pas les recommandations de bonnes pratiques cliniques ? L'exemple du diabète de type 2. Sciences sociales et santé. 24(2). 75–103. 28 indexed citations

11.

Cogneau, Joël, Beverley Balkau, Alain Weill, François Liard, & D. Simon. (2006). Assessment of diabetes screening by general practitioners in France: the EPIDIA Study. Diabetic Medicine. 23(7). 803–807. 11 indexed citations

12.

Sorum, Paul Clay, et al.. (2004). Avoidance of Anticipated Regret: The Ordering of Prostate-Specific Antigen Tests. Medical Decision Making. 24(2). 149–159. 37 indexed citations

13.

Sorum, Paul Clay, et al.. (2003). Why do Primary Care Physicians in the United States and France Order Prostate-Specific Antigen Tests for Asymptomatic Patients?. Medical Decision Making. 23(4). 301–313. 29 indexed citations

14.

Cogneau, Joël, et al.. (2002). Enquête de motivation sur la participation des médecins à une recherche en santé publique. Santé Publique. Vol. 14(2). 191–199. 6 indexed citations

15.

Detournay, B., B Charbonnel, André Grimaldi, et al.. (2000). Managing type 2 diabetes in France: the ECODIA survey.. PubMed. 26(5). 363–9. 68 indexed citations

16.

Petit, H, S. Bakchine, Bruno Dubois, et al.. (1998). [Consensus statement of an interdisciplinary group of French experts on modalities of diagnosis and medical treatment of Alzheimer's disease at a treatable stage].. PubMed. 154(5). 432–8. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact